21
TITLE: Mesenchymal stem cell secretome protects against alpha-synuclein-induced neurodegeneration in a Caenorhabditis elegans model of Parkinson's disease
AUTHORS: Marques, CR; Pereira Sousa, J; Teixeira, FG ; Sousa, RA; Teixeira Castro, A; Salgado, AJ;
PUBLISHED: 2021, SOURCE: CYTOTHERAPY, VOLUME: 23, ISSUE: 10
INDEXED IN: Scopus WOS CrossRef: 5
IN MY: ORCID
22
TITLE: Case Report: A Novel GNB1 Mutation Causes Global Developmental Delay With Intellectual Disability and Behavioral Disorders  Full Text
AUTHORS: Da Silva, JD; Costa, MD; Almeida, B; Lopes, F; Maciel, P ; Teixeira Castro, A;
PUBLISHED: 2021, SOURCE: FRONTIERS IN NEUROLOGY, VOLUME: 12
INDEXED IN: Scopus WOS CrossRef: 9
IN MY: ORCID
23
TITLE: Preclinical Assessment of Mesenchymal-Stem-Cell-Based Therapies in Spinocerebellar Ataxia Type 3
AUTHORS: Correia, JS; Neves Carvalho, A; Mendes Pinheiro, B; Pires, J; Teixeira, FG ; Lima, R; Monteiro, S; Silva, NA ; Soares Cunha, C; Serra, SC; Duarte Silva, S; Teixeira Castro, A; Salgado, AJ; Maciel, P ;
PUBLISHED: 2021, SOURCE: BIOMEDICINES, VOLUME: 9, ISSUE: 12
INDEXED IN: Scopus WOS CrossRef: 1
IN MY: ORCID
24
TITLE: Loss of egli-1, the Caenorhabditis elegans Orthologue of a Downstream Target of SMN, Leads to Abnormalities in Sensorimotor Integration  Full Text
AUTHORS: Da Silva, JD; Oliveira, S; Pereira Sousa, J; Teixeira Castro, A; Costa, MD; Maciel, P ;
PUBLISHED: 2020, SOURCE: MOLECULAR NEUROBIOLOGY, VOLUME: 57, ISSUE: 3
INDEXED IN: Scopus WOS CrossRef: 2
IN MY: ORCID
25
TITLE: Polyglutamine spinocerebellar ataxias: emerging therapeutic targets
AUTHORS: Neves Carvalho, A; Duarte Silva, S; Teixeira Castro, A; Maciel, P ;
PUBLISHED: 2020, SOURCE: EXPERT OPINION ON THERAPEUTIC TARGETS, VOLUME: 24, ISSUE: 11
INDEXED IN: Scopus WOS CrossRef: 9
IN MY: ORCID
26
TITLE: Data on the effects of Hyptis spp. and Lycium spp. plant extracts in C. elegans models of genetically determined neurodegenerative diseases
AUTHORS: Vilasboas Campos, D; Costa, MD; Teixeira Castro, A; Rios, R; Silva, FG; Aierken, A; Zhang, XY; Bessa, C; Dias, ACP ; Maciel, P ;
PUBLISHED: 2020, SOURCE: DATA IN BRIEF, VOLUME: 33
INDEXED IN: Scopus WOS CrossRef: 1 Handle
IN MY: ORCID
27
TITLE: Preclinical Evidence Supporting Early Initiation of Citalopram Treatment in Machado-Joseph Disease  Full Text
AUTHORS: Esteves, S; Oliveira, S; Duarte Silva, S; Cunha Garcia, D; Teixeira Castro, A; Maciel, P ;
PUBLISHED: 2019, SOURCE: MOLECULAR NEUROBIOLOGY, VOLUME: 56, ISSUE: 5
INDEXED IN: Scopus WOS CrossRef: 16 Handle
IN MY: ORCID
28
TITLE: Citalopram Reduces Aggregation of ATXN3 in a YAC Transgenic Mouse Model of Machado-Joseph Disease  Full Text
AUTHORS: Ashraf, NS; Duarte Silva, S; Shaw, ED; Maciel, P ; Paulson, HL; Teixeira Castro, A; Costa, MD;
PUBLISHED: 2019, SOURCE: MOLECULAR NEUROBIOLOGY, VOLUME: 56, ISSUE: 5
INDEXED IN: Scopus WOS CrossRef: 22 Handle
IN MY: ORCID
29
TITLE: From Pathogenesis to Novel Therapeutics for Spinocerebellar Ataxia Type 3: Evading Potholes on the Way to Translation
AUTHORS: Da Silva, JD; Teixeira Castro, A; Maciel, P ;
PUBLISHED: 2019, SOURCE: NEUROTHERAPEUTICS, VOLUME: 16, ISSUE: 4
INDEXED IN: Scopus WOS CrossRef: 43
IN MY: ORCID
30
TITLE: GST-4-Dependent Suppression of Neurodegeneration in C. elegans Models of Parkinson's and Machado-Joseph Disease by Rapeseed Pomace Extract Supplementation  Full Text
AUTHORS: Pohl, F; Teixeira Castro, A; Costa, MD; Lindsay, V; Fiuza Femandes, J; Goua, M; Germano, G; Russell, W; Maciel, P ; Lin, PKT;
PUBLISHED: 2019, SOURCE: FRONTIERS IN NEUROSCIENCE, VOLUME: 13, ISSUE: OCT
INDEXED IN: Scopus WOS CrossRef: 5 Handle
IN MY: ORCID
Page 3 of 5. Total results: 46.